Vimarsana
Biggest News Aggregation in the World

Director Brady News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director Brady. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Brady Today - Breaking & Trending Today

Brady W. Dougan Buys 2,362 Shares of Humacyte, Inc. (NASDAQ:HUMA) Stock - Vimarsana News

Brady W. Dougan Buys 2,362 Shares of Humacyte, Inc. (NASDAQ:HUMA) Stock

Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) Director Brady W. Dougan purchased 2,362 shares of the business’s stock in a transaction that occurred on Tuesday, June 4th. The shares were purchased at an average cost of $6.35 per share, with a total value of $14,998.70. Following the completion of the acquisition, the director now directly […]

SWEPCO helping Kilgore ISD, other districts add electric buses to fleet - Vimarsana News

SWEPCO helping Kilgore ISD, other districts add electric buses to fleet

Southwestern Electric Power Company (SWEPCO) is helping Texas school districts accelerate plans to add electric buses and ensure a smooth and equitable transition as schools diversify their bus fleets.

Lancers find success in second year as a fall field corps - Vimarsana News

Lancers find success in second year as a fall field corps

By all early indications, the move of Mankato 77 Lancers from a summer parade band to a fall field band has happened without a misstep.

M.C. Escher exhibition opens at the Vero Beach Museum of Art - Vimarsana News

M.C. Escher exhibition opens at the Vero Beach Museum of Art

a href= http://www.vbmuseum.org target= _blank The Vero Beach Museum of Art /a announced a new exhibition featuring the works of world-renowned gr

Humacyte (NASDAQ:HUMA) Earns "Overweight" Rating from Cantor Fitzgerald - Vimarsana News

Humacyte (NASDAQ:HUMA) Earns "Overweight" Rating from Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a $6.00 target price on the stock. A number of other analysts have also weighed in on HUMA. Benchmark reaffirmed a buy rating and issued a […]

Source: wkrb13.com